Skip to content
The Nexus
DossierENTITY

patient safety

Coverage of patient safety in the Nexus archive.

Earliest in view: Apr 22 · 18:18 UTCMost recent: Jul 22 · 08:30 UTC
Co-mentioned in this coverage
Recent coverage
  • HEALTHJul 22 · 08:30 UTCSTAT NEWS
    STAT+: Federal health quality research grants worth $109 million ended early

    Federal health research grants worth $109 million were terminated early by the Agency for Healthcare Research and Quality (AHRQ), affecting 78 grants totaling $200 million. Researchers received notices citing a shift in priorities to focus on areas like patient safety, AI, long Covid, and autism. AcademyHealth confirmed the impact on health services researchers, who expressed concerns about their field's future.

  • HEALTHJun 28 · 23:06 UTCBBC HEALTH
    Resident doctors take strike action over pay

    Resident doctors are taking strike action over pay disputes. The British Medical Association (BMA) warned that operations, outpatient appointments, and elective care will be canceled, but emphasized patient safety remains a priority.

  • HEALTHJun 5 · 18:34 UTCTHE HINDU NATIONAL
    MCH incident sparks call for urgent clinical, medical audit of patient care procedures

    The MCH incident has prompted calls for an urgent clinical and medical audit of patient care procedures. Public health expert B. Ekbal highlights systemic failures in healthcare systems rather than individual negligence, urging the Health department to establish robust monitoring protocols to ensure patient safety.

  • HEALTHMay 28 · 00:55 UTCDAILY MAIL
    Nurses and midwives who should have been banned from treating patients worked for up to 12 years

    Nurses and midwives who should have been banned from treating patients due to safety concerns worked for up to 12 years. The revelation highlights potential risks to patient safety and regulatory failures in healthcare oversight.

  • HEALTHApr 22 · 18:18 UTCTHE GUARDIAN WORLD
    HRT provider censured by UK regulator for ‘systemic failures’ that put patients at risk

    Theramex, a UK producer of hormone replacement therapy (HRT) drugs, was censured by regulators for 'systemic failures' including outdated prescribing information and unclear pregnancy warnings. The drug industry's self-regulatory body criticized the company for compliance breaches that endangered patient safety.